Sei Kakinuma

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Matrix stiffness shapes early transcriptional trajectories during hepatic stellate cell activation.

Matrix stiffness shapes early transcriptional trajectories during hepatic stellate cell activation.

Journal: Hepatology international

Published: March 26, 2026

Genetic alterations in hepatocellular carcinoma after sustained virological response in relation to the molecular characterization of metabolic diseases.

Genetic alterations in hepatocellular carcinoma after sustained virological response in relation to the molecular characterization of metabolic diseases.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 09, 2025

Immune-related adverse events in patients with low baseline serum IL-6 treated with durvalumab plus tremelimumab for hepatocellular carcinoma: a case series.

Immune-related adverse events in patients with low baseline serum IL-6 treated with durvalumab plus tremelimumab for hepatocellular carcinoma: a case series.

Journal: Clinical journal of gastroenterology

Published: May 02, 2025

Effect of Immunotherapy on Late Elderly Patients With Unresectable Hepatocellular Carcinoma: A Real-World Clinical Study.

Effect of Immunotherapy on Late Elderly Patients With Unresectable Hepatocellular Carcinoma: A Real-World Clinical Study.

Journal: Cancer medicine

Published: March 31, 2025

Crosstalk via ICAM-1 enhances supportive phenotype of stellate cells and drives hepatocyte proliferation in iPSC-derived hepatic organoids.

Crosstalk via ICAM-1 enhances supportive phenotype of stellate cells and drives hepatocyte proliferation in iPSC-derived hepatic organoids.

Journal: Stem cell reports

Published: December 06, 2024

High serum gamma-glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma.

High serum gamma-glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 03, 2024

Hepatitis B Virus-KMT2B Integration Drives Hepatic Oncogenic Processes in a Human Gene-edited Induced Pluripotent Stem Cells-derived Model.

Hepatitis B Virus-KMT2B Integration Drives Hepatic Oncogenic Processes in a Human Gene-edited Induced Pluripotent Stem Cells-derived Model.

Journal: Cellular and molecular gastroenterology and hepatology

Published: January 23, 2024

Bile acid-FXR signaling facilitates the long-term maintenance of hepatic characteristics in human iPSC-derived organoids.

Bile acid-FXR signaling facilitates the long-term maintenance of hepatic characteristics in human iPSC-derived organoids.

Journal: Cell reports

Published: December 12, 2023

Prognostic significance of C-reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Prognostic significance of C-reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: September 26, 2023

Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades.

Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades.

Journal: PloS one

Published: July 07, 2023

Correction: Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR.

Correction: Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR.

Journal: Journal of gastroenterology

Published: February 09, 2023

Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors.

Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: November 23, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026